REVERSING MULTIDRUG RESISTANCE IN L1210 TUMOR-CELLS BY HYCANTHONE OR CHLOROPHENOXAMINE INVITRO AND INVIVO

被引:1
|
作者
EFFERTH, T [1 ]
KLETT, T [1 ]
MATTERN, J [1 ]
OSSWALD, H [1 ]
POMMERENKE, EW [1 ]
STOHR, M [1 ]
VOLM, M [1 ]
机构
[1] GERMAN CANC RES CTR, INST CHEMOTHERAPY & TOXICOL, W-6900 HEIDELBERG, GERMANY
关键词
MULTIDRUG RESISTANCE; HYCANTHONE; CHLOROPHENOXAMINE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study we demonstrated that hycanthone and chlorophenoxamine can modulate the resistance of multidrug resistant (MDR) murine L1210 leukemia tumor lines in vitro and in vivo. The circumvention of MDR by hycanthone and chlorophenoxamine in vitro was demonstrated by a short-term test using tritiated nucleic acid precursors and by flow cytometrical measurement of accumulation of rhodamine 123. Furthermore, we treated mice bearing resistant L1210 ascites cells with doxorubicin and hycanthone or chlorophenoxamine. Hycanthone in combination with doxorubicin significantly inhibited tumor growth. We also found an improved therapeutic effect of doxorubicin plus chlorophenoxamine. Our results in vitro and in vivo indicate that hycanthone and chlorophenoxamine might be appropriate tools for the circumvention of MDR in human tumors.
引用
收藏
页码:1275 / 1279
页数:5
相关论文
共 50 条
  • [21] COMPARATIVE STUDIES ON PROPERTIES OF LYSOSOMES IN L1210 LEUKEMIC-CELLS UNDER INVIVO AND INVITRO CONDITIONS
    RUNDELL, JO
    SATO, T
    UEDA, H
    BRANDES, D
    LABORATORY INVESTIGATION, 1974, 30 (03) : 279 - 285
  • [22] DIFFERENT EFFECTS OF VINCRISTINE ON METHOTREXATE UPTAKE BY L1210 CELLS AND MOUSE INTESTINAL EPITHELIA INVITRO AND INVIVO
    CHELLO, PL
    DORICK, DM
    SIROTNAK, FM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 121 - 121
  • [23] DIFFERENT EFFECTS OF VINCRISTINE ON METHOTREXATE UPTAKE BY L1210 CELLS AND MOUSE INTESTINAL EPITHELIA INVITRO AND INVIVO
    CHELLO, PL
    SIROTNAK, FM
    DORICK, DM
    CANCER RESEARCH, 1979, 39 (06) : 2106 - 2112
  • [24] THYMIDYLATE SYNTHASE (TS) ACTIVITY IN L1210 CELLS FOLLOWING INVITRO OR INVIVO EXPOSURE TO QUINAZOLINE ANTIFOLATES
    TAYLOR, GA
    JACKMAN, AL
    BALMANNO, K
    CALVERT, AH
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 195 - 195
  • [25] METHOTREXATE INDUCED ALTERATION OF GLYCOLYSIS IN L1210 CELLS INVITRO
    DESOIZE, B
    CARPENTIER, Y
    JARDILLIER, JC
    BIOMEDICINE EXPRESS, 1978, 29 (02): : 58 - 60
  • [26] EFFECT OF METHOTREXATE ON GLYCOLYSIS BY L1210 CELLS CULTURED INVITRO
    CARPENTIER, Y
    DESOIZE, B
    ROLLET, C
    JARDILLIER, JC
    COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 1978, 286 (04): : 375 - 377
  • [27] CYTOCIDAL ACTION OF HOMOHARRINGTONINE ON L1210 CELLS-INVITRO
    XU, CX
    HAN, R
    ACTA PHARMACOLOGICA SINICA, 1989, 10 (06): : 546 - &
  • [28] TENIPOSIDE-RESISTANCE IS MULTIFACETED IN L1210 CELLS
    ROBERTS, D
    YALOWICH, J
    FOGLESONG, D
    ASHMUN, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 267 - 267
  • [29] FK-506 (FUJIMYCIN) REVERSES THE MULTIDRUG RESISTANCE OF TUMOR-CELLS INVITRO
    POURTIERMANZANEDO, A
    BOESCH, D
    LOOR, F
    ANTI-CANCER DRUGS, 1991, 2 (03) : 279 - 283
  • [30] CYTO-TOXICITY AND DNA DAMAGE CAUSED BY THE AZOXY METABOLITES OF PROCARBAZINE IN L1210 TUMOR-CELLS
    ERIKSON, JM
    TWEEDIE, DJ
    DUCORE, JM
    PROUGH, RA
    CANCER RESEARCH, 1989, 49 (01) : 127 - 133